Infliximab for Immune Checkpoint Inhibitor Associated AKI
Infliximab for Immune Checkpoint Inhibitor Associated AKI
Recruiting · NCT07683975 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Infliximab for Immune Checkpoint Inhibitor Associated AKI | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, acute tubulointerstitial nephritis, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 4 | 2026-10-09 | NCT07683975 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 617 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 511 |
| Dana Farber Cancer Institute | Boston | United States | 133 |
| Massachusetts General Hospital | Boston | United States | 1015 |